Zobrazeno 1 - 10 of 25 pro vyhledávání: '"David L. Diuguid"'
2
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on post-discharge thromboprophylaxis
Autor: Antonio Bognanni, David L. Diuguid, Susan R. Kahn, Andrea Darzi, Matthew T. V. Chan, Atefeh Noori, Deborah M. Siegal, Elie A. Akl, Reyad Nayif Al Jabiri, Gian Paolo Morgano, Eric Tseng, Binu A. Philip, Imad Bou Akl, Mary Boulos, Yazan Nayif Al Jabiri, Philipp Kolb, Pantep Angchaisuksiri, Giovanna Muti-Schünemann, Heba Hussein, Rana Charide, Holger J. Schünemann, Angela M. Barbara, Marc Philip Righini, Rami Z. Morsi, Samer G. Karam, Luis Enrique Colunga-Lozano, Frederikus A. Klok, Kamshad Touri, Kathryn Dane, Daniel O. Griffin, Karla Solo, Adam Cuker, Deirdra R. Terrell, Finn Schünemann, Robby Nieuwlaat, Thomas Piggott, Menatalla K. Nadim, Kristen M. Sanfilippo, Ashok Pai, Maria T. DeSancho, Alfred Ian Lee, Clifton Blair, Yuan Qiu, Karin Lee Dearness, Mike Skara, Yetiani Roldan Benitez, Reem A. Mustafa, Ignacio Neumann, Wojtek Wiercioch, Romina Brignardello-Petersen, Jennifer Davila, Razan Mansour, Adrienne Stevens
Publikováno v: Blood Advances
Blood Advances, 6(2), 664-671. ELSEVIER
BackgroundCOVID-19–related acute illness is associated with an increased risk of venous thromboembolism (VTE).ObjectiveThese evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients, clinicians, and oth
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27b11a194efec18c930be70e0dfe2fa4
http://europepmc.org/articles/PMC8566097
Zobrazit plný text záznamu
3
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate intensity anticoagulation in critically ill patients
Autor: Gian Paolo Morgano, David L. Diuguid, Giovanna Muti-Schünemann, Alfred Ian Lee, Holger J. Schünemann, Deirdra R. Terrell, Luis Enrique Colunga-Lozano, Rami Z. Morsi, Frederikus A. Klok, Thomas Piggott, Clifton Blair, Yetiani Roldan, Binu A. Philip, Pantep Angchaisuksiri, Philipp Kolb, Adam Cuker, Kamshad Touri, Romina Brignardello-Petersen, Karla Solo, Atefeh Noori, Adrienne Stevens, Jennifer Davila, Susan R. Kahn, Razan Mansour, Finn Schünemann, Robby Nieuwlaat, Kathryn Dane, Antonio Bognanni, Imad Bou Akl, Eric Tseng, Deborah M. Siegal, Ignacio Neumann, Wojtek Wiercioch, Yuan Qiu, Mike Skara, Matthew T. V. Chan, Andrea Darzi, Marc Philip Righini, Reem A. Mustafa, Rana Charide, Daniel O. Griffin, Elie A. Akl, Mary Boulos, Karin Lee Dearness, Ashok Pai, Maria T. DeSancho, Kristen M. Sanfilippo
Publikováno v: Blood Advances
Blood Advances, 5(20), 3951-3959. ELSEVIER
Background: COVID-19–related critical illness is associated with an increased risk of venous thromboembolism (VTE). Objective: These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients, clinicians,
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2158c5d1ad1e2c49cd13b01801eeea9a
http://europepmc.org/articles/PMC8416320
Zobrazit plný text záznamu
6
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease
Autor: Elliott, Vichinsky, Carolyn C, Hoppe, Kenneth I, Ataga, Russell E, Ware, Videlis, Nduba, Amal, El-Beshlawy, Hoda, Hassab, Maureen M, Achebe, Salam, Alkindi, R Clark, Brown, David L, Diuguid, Paul, Telfer, Dimitris A, Tsitsikas, Ashraf, Elghandour, Victor R, Gordeuk, Julie, Kanter, Miguel R, Abboud, Joshua, Lehrer-Graiwer, Margaret, Tonda, Allison, Intondi, Barbara, Tong, Jo, Howard, Julie, Kanter Washko
Publikováno v: The New England journal of medicine. 381(6)
Deoxygenated sickle hemoglobin (HbS) polymerization drives the pathophysiology of sickle cell disease. Therefore, direct inhibition of HbS polymerization has potential to favorably modify disease outcomes. Voxelotor is an HbS polymerization inhibitor
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b73bdd279bf022b9774c5beb0fb85ce
https://pubmed.ncbi.nlm.nih.gov/31199089
Zobrazit plný text záznamu
7
Clinically suspected heparin-induced thrombocytopenia during extracorporeal membrane oxygenation
Autor: Darryl Abrams, Daryl Glick, Justin Muir, Matthew Bacchetta, Cara Agerstrand, David L. Diuguid, Andrew Eisenberger, Daniel Brodie, Erik Abel, Amy L. Dzierba
Publikováno v: Journal of Critical Care. 30:1190-1194
Purpose Patients receiving extracorporeal membrane oxygenation (ECMO) are at risk for thrombocytopenia including heparin-induced thrombocytopenia (HIT). The purpose of this study was to determine the frequency of suspected HIT in patients receiving E
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::717fc543a84586b1bc4550183340e6da
https://doi.org/10.1016/j.jcrc.2015.07.030
Zobrazit plný text záznamu
8
Abciximab/Heparin Therapy for Left Ventricular Assist Device Implantation in Patients With Heparin-Induced Thrombocytopenia
Autor: David L. Diuguid, Jiho Han, Yoshifumi Naka, Paul Kurlansky, Koji Takeda, Paolo C. Colombo, Hiroo Takayama, Andrew Eisenberger, Chia-Ling Lee, Melana Yuzefpolskaya, Douglas L. Jennings, Arthur R. Garan, Michael Salna
Publikováno v: The Annals of thoracic surgery. 105(1)
Background Optimal anticoagulation strategy remains uncertain in patients with heparin-induced thrombocytopenia (HIT) and undergoing left ventricular assist device (LVAD) implantation. We describe our protocol of abciximab and heparin in these patien
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b573241ef4b4e209a72e1a5a6811fda0
https://pubmed.ncbi.nlm.nih.gov/29371038
Zobrazit plný text záznamu
9
Prior hematologic conditions carry a high morbidity and mortality in patients supported with continuous-flow left ventricular assist devices
Autor: David L. Diuguid, Kanika M. Mody, Arthur R. Garan, Hiroo Takayama, Nir Uriel, Melana Yuzefpolsakaya, Yoshifumi Naka, A.P. Levin, Justin Fried, Ulrich P. Jorde
Publikováno v: The Journal of Heart and Lung Transplantation. 33:1119-1125
Background Mechanical support leads to an increased risk of both bleeding and thrombotic events, but little is known about the risk of device support in patients with a baseline predisposition to these events. The aim of this study was to examine out
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::251e5f9d3a6c16ba8b6d863430ea612b
https://doi.org/10.1016/j.healun.2014.07.002
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje